Research Article
The Relation between Pregnancy-Associated Plasma Protein A and Obstructive Sleep Apnea Syndrome
Table 3
Respiratory function test results.
| | | Control () (mean ± SD) | OSAS () (mean ± SD) | |
| | Forced vital capacity (FVC) (L) | 4.18 ± 0.99 | 4.21 ± 1.09 | 0.913 | | Forced vital capacity (FVC) (%) | 101.32 ± 10.47 | 102.14 ± 13.52 | 0.757 | | Forced expiratory volume (FEV1) (L) | 3.31 ± 0.79 | 3.34 ± 0.87 | 0.843 | | Forced expiratory volume (FEV1) (%) | 96.93 ± 10.53 | 97.64 ± 13.18 | 0.78 | | Forced expiratory volume/forced vital capacity (FEV1/FVC) | 79.14 ± 5.51 | 79.41 ± 5.38 | 0.819 | | Forced expiratory flow (FEF 25–75) (L/sn) | 3.27 ± 1.09 | 3.40 ± 1.12 | 0.594 | | Forced expiratory flow (FEF 25–75) (%) | 81.91 ± 22.43 | 84.61 ± 22.33 | 0.570 | | Peak expiratory flow (L) | 6.64 ± 1.88 | 6.69 ± 1.78 | 0.902 | | Peak expiratory flow (%) | 79.93 ± 16.18 | 81.05 ± 15.61 | 0.748 |
|
|
Independent sample t-test.
|
